Skip to main content
Clinical Trials/NCT04198597
NCT04198597
Completed
Not Applicable

Exploring Two CBT-based Treatments as Interventions for Emotion Dysregulation in Misophonia

Duke University1 site in 1 country12 target enrollmentSeptember 11, 2020
ConditionsMisophonia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Misophonia
Sponsor
Duke University
Enrollment
12
Locations
1
Primary Endpoint
Number of patients who indicate treatment was acceptable to them (i.e., the treatment approach made sense and was perceived as reasonable)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

While the investigators continue to work on better understanding Misophonia, it is also important to identify treatments that can help people who are currently suffering. Further, it is important that the treatments provided are acceptable to the people who receive them. In this study, participants will complete one of two treatments the investigators believe can help manage symptoms of Misophonia: The Unified Protocol or process-based therapy. Both treatments will use evidence-based psychological principles (e.g., managing attention or behavior) in a flexible manner and will focus on developing skills to help reduce the distress and impairment associated with Misophonia. The aims of this study are (1) to explore the acceptability and feasibility of these treatments for individuals who experience Misophonia and (2) to examine whether these treatments help reduce symptoms associated with Misophonia.

Registry
clinicaltrials.gov
Start Date
September 11, 2020
End Date
November 21, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Over age 18
  • Able to read English
  • Meet criteria for interfering symptoms of misophonia
  • Live in North Carolina

Exclusion Criteria

  • Under age 18
  • Current mania
  • Current psychotic disorder
  • Current anorexia
  • Presents with a condition that requires immediate prioritization in treatment (e.g., suicide planning or intent)
  • Has received any treatment specifically for misophonia in the past year

Outcomes

Primary Outcomes

Number of patients who indicate treatment was acceptable to them (i.e., the treatment approach made sense and was perceived as reasonable)

Time Frame: up to 20 weeks

This form has two questions that assess how satisfied patients were with treatment and how acceptable treatment was to them. The remaining three items are open ended questions that allow patients to provide narrative feedback about their experience in treatment.

Number of patients that are satisfied with treatment as measured by the credibility and expectancy questionnaire (CEQ)

Time Frame: up to 20 weeks

The CEQ is a 6-item measure that asks patients about their perceptions of treatment.

Secondary Outcomes

  • Change in misophonia symptoms as assessed by the Misophonia Questionnaire(assessed weekly, up to 24 weeks)
  • Change in depression as measured by the Overall Depression Severity and Impairment Scale(assessed weekly, up to 24 weeks)
  • Change in anxiety as measured by the Overall Anxiety Severity and Impairment Scale(assessed weekly, up to 24 weeks)
  • Change in anger as measured by the Clinical Anger Scale(assessed weekly, up to 24 weeks)
  • Number of patients who use the skills taught in treatment as measured by the Skill Use Questionnaire(assessed weekly, up to 24 weeks)

Study Sites (1)

Loading locations...

Similar Trials